Multimaging™ For Spatialomics Analysis

Developed by ImaBiotech, Multimaging™ is a solution that allows a Qualitative and Quantitative analysis of Mass Spectrometry and Microscopy Images including a dedicated Quality controls monitoring module.

Multimaging™ integrates a large number of proprietary technologies (MSI-Check, V-reader, iCellQuant, Quantinetix, Open-stat, HD-view) that allows to identify, annotate and quantify biomarkers or drugs in a large number of imaging techniques.

 
MorphoMass Technology
 
This is a Proprietary technology developed By ImaBiotech in order to detect more biomarkers, investigate the cell organizations and interactions in disease tissues. This technology quantifies morphology information of each molecule from Multiplex imaging such as Imaging Mass Cytometry, Mass Spectrometry Imaging and Histology. With these information, the software identifies more relevant biomarker linked to the organization or dis-organization of the tissue in pathology. It brings a new level of spatial information, i.e tissue and cell organizations based on molecular signature.

 
 
 

MSI-Check Technology for analysis with confidence

The software includes a module in order to measure the Quality of the data, the reproducibility of your imaging platform. Our patented technology analyse some key parameters in your data in order to allow confident large studies with large cohort of samples

V-READER Technology with no Data reduction

In few seconds, Multimaging™ is able to simultaneously analyze, visualize, quantify 300+ datasets with the same intensity scale, making Multimaging suitable for large preclinical and clinical investigations, and always without data reduction or no compression. It allows to keep the maximum information and save 20% more sensitivity.

Statistical analysis

Open-Stat Technology

Access to a very large number of statistical algorithm for Pre and Post-processing of your data. Multimaging includes a large number of protocols to analyse Mass Spec Image which includes PCA, PLSA, t-Tests, ANOVA tests, Image Segmentation, t-SNE (and others), Machine Learning modules and digital pathology programs to find biomarkers with accuracy and precision.

Quantinetix Technology for Real Interpretation

Multimaging™ have been developed to quantify with high accuracy your drugs or biomarkers. The Software includes different algorithms for LOD determination, linear regression modes and allows you to submit your data to regulatory agencies with confidence, as Imabiotech does every day.

iCellQuant Technology measure drugs in individual cell

With the integration of HD microscopy images and Mass Spectrometry, you can quantify your drugs into specific types of cells to assess the on/off target.

 
 
Image Synchronization and Cloud

An easy way to interpret your data with the same references and same intensity scales to compare your images. you can  also share Data, knowledge and expertise with clients is now possible thanks to the Cloud Multimaging module. For our sponsors and partners, we offer the possibility to take the MSI control from multisite visualization and quantitation of biomarkers and drugs.The HDView module is also compatible making relevant (leveraged) interactions between pathologists.

 

 

 

HD-View Technology

Multimaging is the unique software to overlay Mass Spec Image with High Definition images (up to X100) without image compression and in all your data sets at the same time. It allows to identify histological structure and validate drug and biomarker localization with a very high accuracy.

 
 

Testimony

Raphaël Legouffe, Study Director at ImaBiotech:
« Multimaging is so powerful that it allows us to visualize and analyze dozen of datasets at the same time. On daily basis, for me and my team, it enables us to save several hours. A great solution to accelerate the realization of your projects. Multimaging is also the only solution to increase the sensitivity without loosing or reducing any data. »
Imaging Mass spectrometry

Resources

MediaTitle
Press ReleaseImaBiotech to conduct Pilot Study with GSK to assess ImaBiotech's Multimaging™ Technology
Application NoteMultimaging™ Applied to Skin Distribution Study
Press Release ImaBiotech’s Multimaging™ technology chosen by Galderma
Application NoteKeeping an Eye on Molecular Imaging
Press Release ImaBiotech’s Multimaging™ technology chosen by Dermira

Contact us

I accept to receive the newsletter